Pub. Date : 2021 Aug 1
PMID : 34035084
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Here, we show that VEGF-dependent release of thromboxane A2 (TXA2) triggers Ca2+ transients in tumor cells, culminating in PGE2 secretion and subsequent immune evasion in the early stages of tumorigenesis. | Thromboxane A2 | vascular endothelial growth factor A | Mus musculus |
| 2 | Here, we show that VEGF-dependent release of thromboxane A2 (TXA2) triggers Ca2+ transients in tumor cells, culminating in PGE2 secretion and subsequent immune evasion in the early stages of tumorigenesis. | Thromboxane A2 | vascular endothelial growth factor A | Mus musculus |
| 3 | Notably, treatment with a vascular endothelial growth factor (VEGF) receptor antagonist and an anti-VEGF antibody rapidly suppressed Ca2+ transients and reduced TXA2 and PGE2 concentrations in tumor tissues. | Thromboxane A2 | vascular endothelial growth factor A | Mus musculus |
| 4 | Notably, treatment with a vascular endothelial growth factor (VEGF) receptor antagonist and an anti-VEGF antibody rapidly suppressed Ca2+ transients and reduced TXA2 and PGE2 concentrations in tumor tissues. | Thromboxane A2 | vascular endothelial growth factor A | Mus musculus |
| 5 | Notably, treatment with a vascular endothelial growth factor (VEGF) receptor antagonist and an anti-VEGF antibody rapidly suppressed Ca2+ transients and reduced TXA2 and PGE2 concentrations in tumor tissues. | Thromboxane A2 | vascular endothelial growth factor A | Mus musculus |